Supporting in identifying and obtaining payer scientific advice to inform a Phase III trial design.
Read moreEnabled a biotech to achieve its targets by provision of expert pricing support during a company res...
Read moreOur client wanted to develop a n e-learning training programme to enhance the market access capabili...
Read moreReview of secondary literature and clinical trial databases to understand payer willingness to pay.
Read moreThe objective of this research was to understand the processes and outputs from different European p...
Read moreNICE has recently developed the META tool, to support MedTech manufacturers in the identification of...
Read moreSetting the price abtaining market access for a new pharmaceutical remains one of the biggest commer...
Read moreBiosimilars are becoming more widely available across Europe, with many payers at each level involve...
Read moreThe aim of this study is to compare the key aspects companies must consider when seeking HTA scienti...
Read moreOrphan drugs have important societal value as they improve patient quality of life and address unmet...
Read more